SCHEMBL6017362

SCHEMBL6017362

CC(C)(Cc1ncnc2ccc(N)cc12)OC(=O)N1CCNCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 3/20 0.40
▸ IRAK4 Q9NWZ3 1/20 0.37
▸ NR1H2 P55055 1/20 0.36
▸ AKT1 P31749 1/20 0.36
▸ KIT P10721 2/20 0.36
▸ USP2 O75604 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ CLK4 Q9HAZ1 1/20 0.36
▸ ENPP1 P22413 1/20 0.35
▸ PIK3CD O00329 3/20 0.35
▸ PIK3CA P42336 4/20 0.34
▸ PIK3CB P42338 2/20 0.34
▸ PIK3CG P48736 2/20 0.34
▸ HTT P42858 1/20 0.34
▸ MTNR1B P49286 1/20 0.33
▸ HRH4 Q9H3N8 1/20 0.33
▸ MKNK2 Q9HBH9 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ SCN9A Q15858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6017801 0.85 ALDH1A1 (0.40) IRAK4HTT
SCHEMBL7383181 0.75 CYP3A4 (0.40) NR1H2HTT
SCHEMBL2794112 0.72 KIT (0.59) MAP4K4IRAK4NR1H2AKT1KIT
SCHEMBL2798262 0.69 MAP4K4 (0.41) MAP4K4IRAK4NR1H2KITPIK3CD
SCHEMBL30254155 0.69 ALDH1A1 (0.45) TSHR
SCHEMBL29155320 0.69 SIGMAR1 (0.45) —
SCHEMBL7467892 0.67 MAP4K4 (0.51) MAP4K4NR1H2KITPIK3CA
SCHEMBL22169212 0.66 USP2 (0.39) NR1H2USP2
SCHEMBL30020659 0.66 NAMPT (0.46) KITMKNK2
SCHEMBL4360123 0.65 FAAH (0.38) HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1684694-A2 AKT PROTEIN KINASE INHIBITORS Array Biopharma, Inc. (US) 2006-08-02 — — EP disclosed
WO-2005051304-A2 AKT PROTEIN KINASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2005-06-09 — — WO disclosed
Send feedback